Legal Representation
Attorney
Eva Gullick Frongello
USPTO Deadlines
Application History
24 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
May 20, 2019 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
May 20, 2019 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
Feb 1, 2019 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Oct 19, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Oct 17, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Oct 17, 2018 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Oct 17, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Mar 24, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Mar 22, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Mar 22, 2018 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Mar 22, 2018 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Oct 17, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Aug 22, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Aug 22, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Aug 2, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Jun 23, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jun 21, 2017 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Jun 21, 2017 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
Jun 21, 2017 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Jun 21, 2017 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Jun 20, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Apr 4, 2017 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Apr 3, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Mar 31, 2017 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products utilizing targeted technologies, namely, DNA addressing and specialized delivery mechanisms, for antimicrobial and therapeutic use, for the treatment of infectious diseases, cancer and other genetic diseases
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of a design featuring a gene within a circle. To the right of the design is the phrase "LOCUS BIOSCIENCES" with "LOCUS" in bolded, all capital letters, above the word "BIOSCIENCES", which is also in all-capital letters. The phrase "ENGINEERING PRECISION MEDICINES" is below the words "LOCUS BIOSCIENCES" in all capital letters with a horizontal line running between the word "BIOSCIENCES" and the words "ENGINEERING PRECISION MEDICINES".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"BIOSCIENCES" AND "ENGINEERING PRECISION MEDICINES"